NPM–ALK does not appear to prevent on-going TCRβ rearrangement in human ALCL, as many cases demonstrate clonal populations by PCR (but not by high-resolution CGH) and as such are probably present in 1–20% of the DNA. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.